155 related articles for article (PubMed ID: 27094880)
1. Pyomyositis at the surgical site in a patient with chronic myeloid leukemia: a case report and literature review.
Takebayashi K; Sonoda H; Shimizu T; Ohta H; Minamiguchi H; Ishida M; Mekata E; Endo Y; Tani T; Tani M
World J Surg Oncol; 2016 Apr; 14():116. PubMed ID: 27094880
[TBL] [Abstract][Full Text] [Related]
2. Bilateral hip pain caused by adductor pyomyositis as the initial presentation of chronic myeloid leukemia in a 17-year-old child.
Chen MC; Yang SH; Yao TK; Chong PN; Chen SH
Pediatr Neonatol; 2011 Dec; 52(6):353-7. PubMed ID: 22192265
[TBL] [Abstract][Full Text] [Related]
3. Newly diagnosed breast cancer in a patient receiving imatinib mesylate.
Kaygusuz-Atagunduz I; Toptas T; Yumuk F; Firatli-Tuglular T; Bayik M
J Cancer Res Ther; 2014; 10(4):1107-8. PubMed ID: 25579564
[TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate induced erythroderma: A rare case series.
Kumar S; Mahajan BB; Kaur S; Banipal RP; Singh A
J Cancer Res Ther; 2015; 11(4):993-6. PubMed ID: 26881566
[TBL] [Abstract][Full Text] [Related]
5. Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: a case report and review of the literature.
Rujirachun P; Junyavoraluk A; Owattanapanich W; Suvannarerg V; Sirinvaravong S
J Med Case Rep; 2018 Sep; 12(1):257. PubMed ID: 30196795
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Campione E; Diluvio L; Paternò EJ; Di Marcantonio D; Francesconi A; Terrinoni A; Orlandi A; Chimenti S
Clin Ther; 2009 Nov; 31(11):2565-9. PubMed ID: 20110001
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma in a chronic myelogenous leukemia patient treated with imatinib mesylate.
Fujii M; Iwasaki T; Takahashi I; Kishiyama K; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
J Dermatol; 2015 Mar; 42(3):338-9. PubMed ID: 25580575
[No Abstract] [Full Text] [Related]
8. Imatinib-induced diffuse hyperpigmentation of the oral mucosa, the skin, and the nails in a patient affected by chronic myeloid leukemia: report of a case and review of the literature.
Di Tullio F; Mandel VD; Scotti R; Padalino C; Pellacani G
Int J Dermatol; 2018 Jul; 57(7):784-790. PubMed ID: 29417559
[TBL] [Abstract][Full Text] [Related]
9. [Postoperative Adjuvant Chemotherapy for Descending Colon Cancer Treated with Imatinib for Chronic Myeloid Leukemia].
Tatsuta K; Harada T; Miyazaki S; Ogiku M; Hayashi T; Tamura H; Kanai T; Ikematsu Y; Naito K; Nishiwaki Y
Gan To Kagaku Ryoho; 2019 Aug; 46(8):1319-1321. PubMed ID: 31501379
[TBL] [Abstract][Full Text] [Related]
10. Second primary malignancies in chronic myeloid leukemia patients.
Caliskan T; Eskazan AE
J Cancer Res Ther; 2015; 11(4):1042. PubMed ID: 26881669
[No Abstract] [Full Text] [Related]
11. Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report.
Elm'hadi C; Khmamouche MR; Tanz R; Toreis M; Mahtat E; Allaoui M; Oukabli M; Messaoudi N; Errihani H; Ichou M
J Med Case Rep; 2017 Jan; 11(1):10. PubMed ID: 28069070
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia.
Batrani M; Salhotra M; Kubba A; Agrawal M
Indian J Dermatol Venereol Leprol; 2016; 82(6):727-729. PubMed ID: 27716725
[No Abstract] [Full Text] [Related]
13. [A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].
Suzuki K; Sekine T
Kansenshogaku Zasshi; 2014 May; 88(3 Suppl 9-10):33-6. PubMed ID: 24979952
[TBL] [Abstract][Full Text] [Related]
14. Uncontrolled neovascular glaucoma - an alarming manifestation of chronic myeloid leukemia on imatinib therapy - a case report and review of literature.
Roop P; Angmo D; Kamble N; Tomar AS
Indian J Ophthalmol; 2019 Feb; 67(2):285-287. PubMed ID: 30672497
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes.
Stagno F; Stella S; Spitaleri A; Pennisi MS; Di Raimondo F; Vigneri P
Expert Rev Anticancer Ther; 2016; 16(3):273-8. PubMed ID: 26852913
[TBL] [Abstract][Full Text] [Related]
16. A case report of rare palmoplantar keratosis and nail dystrophy with imatinib.
Benabbes M; Tazi Mezalek Z; Meddah B
Ann Pharm Fr; 2017 May; 75(3):172-175. PubMed ID: 28189257
[TBL] [Abstract][Full Text] [Related]
17. Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia.
Bhagavathi S; Borromeo V; Desai H; Crisan D
Ann Clin Lab Sci; 2008; 38(4):405-9. PubMed ID: 18988937
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease.
Yhim HY; Lee NR; Song EK; Yim CY; Jeon SY; Lee B; Kim JA; Kim HS; Cho EH; Kwak JY
Acta Haematol; 2016; 135(3):133-9. PubMed ID: 26535871
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis.
Yamasawa H; Sugiyama Y; Bando M; Ohno S
Respiration; 2008; 75(3):350-4. PubMed ID: 16449804
[TBL] [Abstract][Full Text] [Related]
20. Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia.
Scott AD; Lee M; Kubba F; Chu A
Clin Exp Dermatol; 2015 Dec; 40(8):926-7. PubMed ID: 25266712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
